The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

AstraZeneca

Status: Completed

Conditions: Schizophrenia; Bipolar Disorders; Major Depressive Disorders

Study type: Observational

Funder types: Industry

Identifiers

NCT01377896

NIS-NZA-XXX-2011/1

Details and patient eligibility

About

'Real life' retrospective patient cases (10) to provide an objective and robust analytical report of patient management and prescriptions behaviours for Schizophrenia, Bipolar disorders and Major depressive disorders.

Enrollment: 221 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with one of the following conditions: Schizophrenia, Bipolar disorders and Major depressive disorders.

Exclusion criteria

• Patients who have not been diagnosed with the conditions as outlined in the Inclusion criteria.